EcoR1 Capital as of June 30, 2015
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 25 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Atara Biotherapeutics | 18.7 | $56M | 1.1M | 52.76 | |
| Epizyme | 13.5 | $41M | 1.7M | 24.00 | |
| Assembly Biosciences | 10.1 | $30M | 1.6M | 19.26 | |
| Fibrogen | 9.4 | $28M | 1.2M | 23.50 | |
| ARRAY BIOPHARMA SR CONV NT 3.000% Due 06/01/2020 Note (Principal) | 8.1 | $24M | 19M | 1.26 | |
| Kite Pharma | 5.7 | $17M | 281k | 60.97 | |
| Flex Pharma | 5.2 | $16M | 909k | 17.20 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 5.2 | $16M | 837k | 18.52 | |
| Retrophin | 3.8 | $11M | 342k | 33.15 | |
| Kindred Biosciences | 2.9 | $8.8M | 1.3M | 6.82 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 2.8 | $8.3M | 465k | 17.84 | |
| Array Biopharma Call Option | 2.6 | $7.9M | 11k | 721.04 | |
| Ovascience Inc call Call Option | 2.2 | $6.7M | 2.3k | 2893.33 | |
| Forward Pharma A/s Sponsored Adr | 2.0 | $6.0M | 159k | 38.05 | |
| Genvec | 1.4 | $4.1M | 2.0M | 2.04 | |
| Celladon | 1.2 | $3.6M | 2.8M | 1.26 | |
| Calithera Biosciences | 1.0 | $3.0M | 416k | 7.14 | |
| Array BioPharma | 1.0 | $2.9M | 400k | 7.21 | |
| Biotie Therapies Oyj Sponsored Adr | 0.7 | $2.0M | 100k | 19.97 | |
| Targacept | 0.6 | $1.7M | 620k | 2.79 | |
| Seres Therapeutics | 0.6 | $1.7M | 40k | 41.50 | |
| Qlt | 0.6 | $1.7M | 400k | 4.13 | |
| Regulus Therapeutics Call Option | 0.5 | $1.4M | 1.3k | 1096.09 | |
| Xenon Pharmaceuticals (XENE) | 0.3 | $842k | 73k | 11.53 | |
| Epizyme Inc call Call Option | 0.1 | $360k | 150.00 | 2400.00 |
